StockUK listing UK0DYQLSEValue Trap

Cegedim S.A.(0DYQ) Stock Analysis

EUR --+0.00%
Reward52Moderate
Risk44Moderate
75%Data
Thin 1% profit margin
EUR —+0.00 (+0.00%) Previous close · LSE
Market cap 166.24M
Reward Rating52 Moderate reward assessment · 75% data coverage
Bottom 50% of stocksView factors
Risk Rating44 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on 0DYQ to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Cegedim S.A.?

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare and B2B ecosystem in France, rest of Europe, the Middle East, Africa, and internationally.

AI Brief Pro

The brief on Cegedim S.A.

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Cegedim S.A.?

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare and B2B ecosystem in France, rest of Europe, the Middle East, Africa, and internationally. The company offers practice management, pharmacy management, healthcare center management, and MSP management software, as well as drug database and hosting of healthcare data for doctor, dentist, pharmacist, nurse, physiotherapist, podiatrist, speech therapist, midwife, and administrator health center; and drug distribution statistics, digital promotion of non-REPS medication, point of sale promotion, and restocking drug solutions for marketing and ADV pharma. The company is listed on the LSE in UK, with a market capitalisation of 166.24M, and a P/E ratio of 0.1x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (52)
Company Information
SectorN/A
IndustryN/A
Market Cap166.24M
P/E Ratio0.0549
Beta0.619
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.